These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4147678)

  • 21. [Therapeutic use of Sandomigran (BC-105)].
    Prusiński A; Niewodniczy A
    Wiad Lek; 1974 Feb; 27(3):297-300. PubMed ID: 4839710
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic results of prophylactic treatment for "classic" migraine with antaminic substance (B P 400 Sandoz).
    Dalsgaard-Nielsen T
    Headache; 1968 Apr; 8(1):6-15. PubMed ID: 4384742
    [No Abstract]   [Full Text] [Related]  

  • 23. The treatment of migraine with BC 105 (pizotifen): a double blind trial.
    Arthur GP; Hornabrook RW
    N Z Med J; 1971 Jan; 73(464):5-9. PubMed ID: 4925988
    [No Abstract]   [Full Text] [Related]  

  • 24. The prophylactic treatment of migraine with an antiserotonin pizotifen.
    Hübbe P
    Acta Neurol Scand; 1973; 49(1):108-14. PubMed ID: 4567747
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sandomigrin (pizotiphenum NFN) in migraine prevention].
    Jorgensen RS
    Ugeskr Laeger; 1973 Nov; 135(46):2528. PubMed ID: 4781855
    [No Abstract]   [Full Text] [Related]  

  • 26. [Usefulness of Sandomigran in treatment of migraine syndromes].
    Wasilewski R
    Pol Tyg Lek; 1973 Aug; 28(34):1320-1. PubMed ID: 4756402
    [No Abstract]   [Full Text] [Related]  

  • 27. Migraine as a cyclic disease with latent and overt components--effects with an antaminic drug.
    Sicuteri F; Del Bianco PL; Ansemli B
    Headache; 1970 Jul; 10(2):53-62. PubMed ID: 4192978
    [No Abstract]   [Full Text] [Related]  

  • 28. [Zung's test for the quantitative assessment of depression and its confirmation during the testing of a new anti-migraine agent Sandomigran].
    Klapetek J
    Cesk Neurol; 1973 Sep; 36(5):298-303. PubMed ID: 4581588
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical experiences with polyantiaminic BC-105 Sandoz in the prevention of vasomotor headaches].
    Sercl M; Vrcha L
    Schweiz Rundsch Med Prax; 1970 May; 59(18):679-83. PubMed ID: 4396441
    [No Abstract]   [Full Text] [Related]  

  • 30. Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.
    Speight TM; Avery GS
    Drugs; 1972; 3(3):159-203. PubMed ID: 4403890
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative trial of serotonin antagonists in the management of migraine.
    Lance JW; Anthony M; Somerville B
    Br Med J; 1970 May; 2(5705):327-30. PubMed ID: 4393372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical trial of an antiserotonin drug, bc-105 in the prophylaxis of migraine.
    Selby G
    Proc Aust Assoc Neurol; 1970; 7():37-43. PubMed ID: 4937097
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experience with a new serotonin antagonist in the prevention of migraine].
    Kollin E
    Orv Hetil; 1971 Aug; 112(35):2090 passim. PubMed ID: 5129040
    [No Abstract]   [Full Text] [Related]  

  • 34. [Functioning malignant carcinoid (case report. Preliminary results of treatment with 3 new drugs)].
    Sillero J; De Cañete F; Moreno Quesada A; Salido Sánchez A
    Rev Clin Esp; 1969 Nov; 115(4):287-98. PubMed ID: 4392338
    [No Abstract]   [Full Text] [Related]  

  • 35. Seminar on headache.
    Can Med Assoc J; 1971 Jul; 105(1):89-92. PubMed ID: 5088482
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison between BC 105 and methysergide in the prophylaxis of migraine.
    Forssman B; Henriksson KG; Kihlstrand S
    Acta Neurol Scand; 1972; 48(2):204-12. PubMed ID: 4556413
    [No Abstract]   [Full Text] [Related]  

  • 37. [Controlled clinical trials of an oral anti-allergic agent (author's transl)].
    Horak F; Hussarek M
    Schweiz Rundsch Med Prax; 1977 Oct; 66(41):1321-4. PubMed ID: 20614
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison between desinsitization with pollen and administration of a new inhibiting agent of releasing histamin, "ketotifene" (author's transl)].
    Martin-du-Pan R
    Schweiz Rundsch Med Prax; 1978 Jul; 67(29):1085-7. PubMed ID: 27777
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ketotifen--a new anti-asthma drug].
    Droszcz W
    Pol Arch Med Wewn; 1980 Jan; 63(1):95-7. PubMed ID: 6102378
    [No Abstract]   [Full Text] [Related]  

  • 40. The protective effect of a new oral anti-asthma agent (ketotifen, HC 20--511) against experimentally induced bronchospasm (5 different models).
    Wuethrich B; Radielovic P; Debelic M
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):424-9. PubMed ID: 29841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.